Simtra BioPharma Solutions, a CDMO specializing in injectable medicines, has opened a more than $250-million expansion of its Bloomington, Indiana, manufacturing campus. The 153,000-square-foot building adds new prefilled syringe, vial, and lyophilization capabilities. 

The expansion is part of Simtra’s broader global growth strategy, which also includes more than $125 million invested in expanded manufacturing capacity at its site in Halle, Germany, and an initial investment of more than $150 million at its Bloomington Park Campus. Across its US and European network, Simtra says it plans to grow from 11 filling lines to 18 by 2027.   

Source: Simtra BioPharma Solutions